Blog Archive

Sunday, August 21, 2016

Baxalta, now part of Shire

Powered by their commitment to you.

There’s been a lot of change in our community this year, but perhaps none so impactful as the change in Baxalta, now a part of Shire. Please read below to learn more about these changes, and click through to learn how Shire will keep on serving you!

Shire, is built on strength and experience, and is powered by an enduring commitment to you. Each company brings world-class products, as well as, a foundation for sustained category leadership in rare diseases.

Combining 60 years with 30 years of dedicated history to bleeding and rare disorders communities, the new company has even more resources to offer. What that means for patients is that Shire is maintaining its solid commitment to you while still offering innovative products. Introducing new treatments for bleeding disorders, and making a meaningful difference in the lives of patients and families continues to be Shire’s main focus.

Shire’s combined product offerings have expanded the range of therapeutic areas. Shire and Baxalta are combining 30 years with 60 years of dedicated history to the rare disease and hematology community. Together they are commitment to the hematology community.


This is a paid announcement by Baxalta, now part of Shire.





August 2016

USBS/MG1/16-0527a
 
Bayer